Usenius J P, Ruopuro M L, Usenius R
Department of Urology, Central Hospital, Jyvaskyla, Finland.
Br J Urol. 1988 Dec;62(6):521-4. doi: 10.1111/j.1464-410x.1988.tb04418.x.
We report the first patient in Finland and Scandinavia with a deficiency of adenine phosphoribosyltransferase (APRT). About 30 clinically affected patients have been reported in the literature. APRT deficiency is an enzyme disorder which is inherited autosomally in a recessive manner. The use of adenine in purine metabolism is disturbed and it accumulates in the body, where it is oxidised to poorly insoluble 2,8-dihydroxyadenine by xanthine oxidase. The dihydroxyadenine forms stones which can be mistaken for uric acid stones. Our patient had had frequent episodes of urolithiasis and the diagnosis was finally made after pyelolithotomy and stone analysis. The total APRT deficiency was detected in the haemolysate of erythrocytes. Partial deficiency of APRT in the patient's relatives showed heterozygosity of the enzyme defect. The only clinical manifestation of the defect is the formation of urinary stones. This can be prevented by diet and allopurinol.
我们报告了芬兰和斯堪的纳维亚半岛首例腺嘌呤磷酸核糖转移酶(APRT)缺乏症患者。文献中已报道约30例有临床症状的患者。APRT缺乏症是一种以隐性方式常染色体遗传的酶紊乱疾病。嘌呤代谢中腺嘌呤的利用受到干扰并在体内蓄积,在体内被黄嘌呤氧化酶氧化为难溶性的2,8 - 二羟基腺嘌呤。二羟基腺嘌呤形成结石,可能被误认为尿酸结石。我们的患者有频繁的尿路结石发作,最终在肾盂切开取石术和结石分析后做出诊断。在红细胞溶血产物中检测到APRT完全缺乏。患者亲属中APRT部分缺乏显示出该酶缺陷的杂合性。该缺陷唯一的临床表现是尿路结石的形成。这可以通过饮食和别嘌呤醇来预防。